May 11, 2023 11:30AM
Feb 10, 2023 08:19AM
Oct 27, 2022 09:22AM
Oct 16, 2022 07:12AM
Aug 9, 2022 05:00AM
May 4, 2022 08:36AM
Mar 25, 2022 01:23PM Kintor Pharma Announces 2021 Business Progress and Annual Results
Mar 1, 2022 07:30AM
Feb 3, 2022 07:32AM
Jan 24, 2022 08:47AM
Nov 24, 2021 10:14AM
Nov 12, 2021 01:17AM
Nov 2, 2021 08:32PM
Oct 4, 2021 04:30AM Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US
Aug 29, 2021 09:46PM
Jul 28, 2021 01:47AM
Jul 16, 2021 02:41AM
Jul 14, 2021 10:00PM
Jul 13, 2021 07:05PM
Jul 11, 2021 09:03AM
May 19, 2021 09:47PM Kintor Announced (1) FDA Has Greenlighted Proxalutamide's Phase III Study for Hospitalized Male and Female COVID-19 Patients to Be Conducted; and (2) Inclusion of Female Outpatients in Proxalutamide's
Apr 25, 2021 09:00AM
Apr 16, 2021 06:29AM
Apr 14, 2021 10:18AM
Mar 26, 2021 08:54AM
Mar 5, 2021 08:00AM

324,381 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All